Djamila Messous - Concepedia

Author

Djamila Messous

Also Known As

D MESSOUS, D Messous, D. MESSOUS, D. Messous, DJAMILA MESSOUS, Djamila Messous, Frederic Charlotte, Messous Djamila, Messous, Djamila

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Pitié-Salpêtrière Hospital Biopredic (France)Assistance Publique – Hôpitaux de Paris Centre National de la Recherche Scientifique

About

Djamila Messous is an author at Sorbonne Université specializing in pathology, medicine, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	943
2	Health Sciences	7	7	671
3	Biostatistics	2	2	27
4	Biochemistry	1	1	16
5	Diabetes	1	1	64

Djamila Messous

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease Vlad Ratziu, Julien Massard, Frédéric Charlotte, BMC Gastroenterology	2006	481
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis Thierry Poynard, Vlad Ratziu, Sylvie Naveau, Comparative Hepatology	2005	359
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Thierry Poynard, Françoise Imbert‐Bismut, M. Munteanu, Comparative Hepatology	2004	355
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C Thierry Poynard, M. Munteanu, Françoise Imbert‐Bismut, Clinical Chemistry	2004	344
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B Robert P. Myers, Marie-Hélène Tainturier, Vlad Ratziu, Journal of Hepatology Biochemical MarkersHepatologyViral HepatitisLiver PhysiologyHepatitis B	2003	337
A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C Yen Ngo, M. Munteanu, Djamila Messous, Clinical Chemistry	2006	228
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial Thierry Poynard, Françoise Imbert‐Bismut, Vlad Ratziu, Journal of Viral Hepatitis	2002	223
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) Thierry Poynard, Pascal Lebray, Patrick Ingiliz, BMC Gastroenterology	2010	199
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease Sylvie Naveau, Bruno Raynard, Vlad Ratziu, Clinical Gastroenterology and Hepatology Prognostic BiomarkersLiver FibrosisFibrosisHepatologyNonalcoholic Fatty Liver Disease	2005	160
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Françoise Imbert‐Bismut, Djamila Messous, V Thibaut, Clinical Chemistry and Laboratory Medicine (CCLM)	2004	132

Page 1